Relative Bioavailability Study to Investigate and to Compare Two Different Formulations of Hyoscine Butylbromide in Healthy Male and Female Volunteers

Summary

The objective of the current trial is to establish the bioequivalence of 2 hyoscine butylbromide dose forms following oral administration.

Timeline

Start

2012-11-01

Primary completion

2012-12-01

Completion

2012-12-01

Drugs

Indications

No indication recorded.